Editorial: Evidence for Assessing Drug Safety and Drug Use in Older People

Overview

Journal Front Pharmacol

Date 2022 Jun 20

PMID 35721158

Authors

Luciane Cruz Lopes

Ria Benko

Marcio Galvao Oliveira

Vera Maria Vieira Paniz

Brian Godman

Fabiane Raquel Motter

Affiliations

Soon will be listed here.

References

Xu Z, Liang X, Zhu Y, Lu Y, Ye Y, Fang L . Factors associated with potentially inappropriate prescriptions and barriers to medicines optimisation among older adults in primary care settings: a systematic review. Fam Med Community Health. 2021; 9(4). PMC: 8603289. DOI: 10.1136/fmch-2021-001325. View

Maher R, Hanlon J, Hajjar E . Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2013; 13(1):57-65. PMC: 3864987. DOI: 10.1517/14740338.2013.827660. View

Shah B, Hajjar E . Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin Geriatr Med. 2012; 28(2):173-86. DOI: 10.1016/j.cger.2012.01.002. View

Nobili A, Garattini S, Mannucci P . Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium. J Comorb. 2017; 1:28-44. PMC: 5556419. DOI: 10.15256/joc.2011.1.4. View

Malmstrom R, Godman B, Diogene E, Baumgartel C, Bennie M, Bishop I . Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs. Front Pharmacol. 2013; 4:39. PMC: 3653065. DOI: 10.3389/fphar.2013.00039. View

Motter F, Fritzen J, Hilmer S, Paniz E, Paniz V . Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol. 2018; 74(6):679-700. DOI: 10.1007/s00228-018-2446-0. View

Khatter A, Moriarty F, Ashworth M, Durbaba S, Redmond P . Prevalence and predictors of potentially inappropriate prescribing in middle-aged adults: a repeated cross-sectional study. Br J Gen Pract. 2021; 71(708):e491-e497. PMC: 8136579. DOI: 10.3399/BJGP.2020.1048. View

Komen J, Pottegard A, Mantel-Teeuwisse A, Forslund T, Hjemdahl P, Wettermark B . Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries. Europace. 2021; 23(11):1722-1730. PMC: 8576279. DOI: 10.1093/europace/euab091. View

Motter F, Hilmer S, Paniz V . Pain and Inflammation Management in Older Adults: A Brazilian Consensus of Potentially Inappropriate Medication and Their Alternative Therapies. Front Pharmacol. 2019; 10:1408. PMC: 6901010. DOI: 10.3389/fphar.2019.01408. View

10.

Oliveira M, Amorim W, Jesus S, Rodrigues V, Passos L . Factors associated with potentially inappropriate medication use by the elderly in the Brazilian primary care setting. Int J Clin Pharm. 2012; 34(4):626-32. DOI: 10.1007/s11096-012-9656-9. View

11.

Motter F, Cantuaria N, Lopes L . Healthcare professionals' knowledge, attitudes and practices toward deprescribing: a protocol of cross-sectional study (Desmedica Study-Brazil). BMJ Open. 2021; 11(8):e044312. PMC: 8330586. DOI: 10.1136/bmjopen-2020-044312. View

12.

Mueller T, Alvarez-Madrazo S, Robertson C, Wu O, Bennie M . Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland. Br J Clin Pharmacol. 2018; 85(2):422-431. PMC: 6339970. DOI: 10.1111/bcp.13814. View

13.

Aggarwal P, Woolford S, Patel H . Multi-Morbidity and Polypharmacy in Older People: Challenges and Opportunities for Clinical Practice. Geriatrics (Basel). 2020; 5(4). PMC: 7709573. DOI: 10.3390/geriatrics5040085. View